MIH
ABEO icon

Meitav Investment House’s Abeona Therapeutics ABEO Stock Holding History

Meitav Investment House’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,880
Closed -$137K – 384
2021
Q3 		$137K Hold
4,880
– – ﹤0.01% 388
2021
Q2 		$190K Buy
4,880
+960
+24% +$39.2K ﹤0.01% 392
2021
Q1 		$184 Buy
3,920
+240
+7% +$13.2K 0.01% 362
2020
Q4 		$144K Buy
3,680
+1,200
+48% +$40.9K 0.01% 404
2020
Q3 		$63K Buy
2,480
+1,280
+107% +$80.7K ﹤0.01% 391
2020
Q2 		$87K Buy
+1,200
New +$82.9K 0.01% 378

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Meitav Investment House's ABEO Position: Q4 2021 in Review

Meitav Investment House sold out of Abeona Therapeutics (ABEO) in Q4 2021, closing a stake of 4,880 shares — an estimated $137K sold.

Meitav Investment House first reported a position in ABEO in Q2 2020 and held it in 6 quarters. The position peaked at $190K in Q2 2021. 52 funds tracked by Wall St. Rank hold ABEO as of Q4 2021.

  • Meitav Investment House reported no remaining Abeona Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Meitav Investment House sold 4,880 Abeona Therapeutics shares in Q4 2021, an estimated $137K.
  • Meitav Investment House first reported a position in Abeona Therapeutics in Q2 2020 and held it in 6 quarters.
  • Meitav Investment House's Abeona Therapeutics position peaked at $190K in Q2 2021.
  • 52 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2021.

Based on Meitav Investment House's 13F filing for Q4 2021, filed 8 Feb 2022.